cipla

Cipla shares climbed 9 per cent in Thursday’s trade on Thursday after the pharma company reported robust earnings for the first quarter of FY24. US revenues for Q1 were the highest ever. Despite limited period gRevlimid cash flow, Cipla has…

Stocks to Watch on July 28: Nifty futures traded 34 points, or 0.17 per cent, higher at 19,798, signaling that Dalal Street was headed for a positive start on Friday. Here’s a slew of stocks that will be in focus today for various…

MUMBAI: Drug major Cipla's promoters are in talks with private equity (PE) biggies, including Blackstone, Adventand KKR, to sell a part of their holding in the company. The promoters are believed to have mandated Kotak for the exercise,…

The Nifty futures contract traded on the Singapore Exchange indicates a negative start to domestic equities. The contract was trading at 18,292, down 58 points or 0.32% from the previous close.Q4FY23 earnings: Tata Motors, Hindustan…

The Nifty futures contract traded on the Singapore Exchange indicates a positive start to domestic equities. The contract was trading at 17,713, up 28 points or 0.16% from the previous close.Cipla: Cipla has signed a perpetual license…

The United Nations-backed public health organisation Medicines Patent Pool has signed sublicense agreements with Aurobindo Pharma, Cipla and Viatris (through its subsidiary Mylan) under which the drugmakers will manufacture generic versions…

Last Updated: March 15, 2023, 08:20 ISTDomestic markets are likely to snap four-day losing streak and turn positive on Wednesday, as global sentiments improve on in-line US inflation report. Globally, the US markets inched higher overnight…

Analysts have turned cautious on Cipla, as the recently issued form 483 by the US FDA with eight observations to its Pithampur (Indore) plant is expected to delay the launch of the company’s key generic – Advair – in the US. Photograph:…

Last Updated: February 20, 2023, 10:40 ISTOn conclusion of the inspection, Cipla has received eight inspectional observations in Form 483. (Representational pic/AP)Cipla will work closely with the USFDA and is committed to address these…

Last Updated: February 20, 2023, 07:51 ISTStocks to Watch on MondayStocks to watch: Shares of firms like Motherson, Sun Pharma, HUL, Dilip Buildcon, Cipla and Zydus will be in focus in today's tradeEquity investors will focus on global…